A new Alzheimer type dementia diagnostic treatment has been approved in Korea, the first time in Asia

Published: 2014-12-24 13:25:26

Updated: 2014-12-24 13:25:38

After the FDA in the U.S. and the EMA in Europe, a new Alzheimer type dementia treatment has been permitted by the Ministry of Food and Drug Safety for the third time.

The new drug, titled ‘Nuraceq (Flobetaben F18)’, is a radiopharmaceutical used in PET/CT scans, which the German company, Bayer, led the development and PiramalImagingSA commercialized and acquired permission in the U.S. (20 Mar...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.